Recently, it has been reported that patients with GS may be at an increased risk for developing T2DM,[10,11] which is a type of diabetes due to a progressive loss of β-cell insulin secretion, frequently caused by insulin resistance. This evidence concerns the gene INS and type 2 diabetes mellitus.